Hunan Er-Kang Pharmaceutical Co., Ltd. (300267)
XSHE XSHE Primary Summary
Hunan Er-Kang Pharmaceutical Co., Ltd. (300267) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Hunan Er-Kang Pharmaceutical Co., Ltd. ever had a stock split?
Hunan Er-Kang Pharmaceutical Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Qingrong Sun CEO | XSHE Exchange | CNE100001781 ISIN |
| China Country | 1,453 Employees | 9 Jun 2023 Last Dividend | 10 May 2016 Last Split | 27 Sep 2011 IPO Date |
Overview
Hunan Er-Kang Pharmaceutical Co., Ltd is a prominent enterprise engaged in the manufacturing and global distribution of Active Pharmaceutical Ingredients (APIs), finished drug products, and pharmaceutical excipients. Established in 2003 and headquartered in Changsha, China, the company has grown to become a key player in the pharmaceutical industry, contributing significantly to both domestic and international markets. By focusing on the production of high-quality pharmaceutical components and medicines, Hunan Er-Kang Pharmaceutical has solidified its reputation as a trusted supplier in the healthcare sector.
Products and Services
Hunan Er-Kang Pharmaceutical Co., Ltd offers a comprehensive range of products and services, encompassing APIs, finished drug products, and pharmaceutical excipients, each serving critical roles in the pharmaceutical manufacturing process:
- Active Pharmaceutical Ingredients (APIs): This category includes essential chemicals such as glycerin, dilute hydrochloric acid, sulbenicillin sodium, dihydroxypropyl theophylline, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. These APIs are the foundational compounds used in the formulation of various drugs, providing the primary therapeutic effects.
- Finished Drug Products: Hunan Er-Kang focuses on producing finished pharmaceuticals like sulbenicillin sodium for injection and compound liquorice tablets. These products are ready for clinical use and are developed to meet stringent quality and efficacy standards, ensuring patient safety and therapeutic effectiveness.
- Conventional Pharmaceutical Excipients: Includes crucial components such as pharmaceutical glycerin, medicinal ethanol, medicinal propylene glycol, medicinal sodium hydroxide, and sucrose. These substances are used in drug formulation to aid in the manufacturing process, improve the stability and usability of pharmaceuticals, and enhance patient acceptance.
- New Pharmaceutical Excipients: The company is also involved in the development and production of innovative excipients like hydroxypropyl starch empty capsules, hydroxypropyl starch soft capsules, and citrate and its series products. These new excipients are designed to enhance drug delivery, improve bioavailability, and provide better drug release profiles, thereby elevating the overall efficacy of medications.
